Trials / Conditions / Spinocerebellar Ataxia Type 6

Spinocerebellar Ataxia Type 6

12 registered clinical trials studyying Spinocerebellar Ataxia Type 6 — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Pivotal Study of N-acetyl-L-leucine for CACNA1A NCT07221292	IntraBio Inc	Phase 3
Not Yet Recruiting	Interposed Nucleus aDBS for Ataxia NCT07325487	University of Florida	N/A
Recruiting	Deep Brain Stimulation for Spinocerebellar Ataxia NCT07288437	University of California, San Francisco	N/A
Not Yet Recruiting	Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia NCT03378414	Sclnow Biotechnology Co., Ltd.	Phase 2
Active Not Recruiting	Priming Motor Learning Through Exercise in People With Spinocerebellar Ataxia NCT05826171	Teachers College, Columbia University	N/A
Withdrawn	Study of CAD-1883 for Spinocerebellar Ataxia NCT04301284	Cadent Therapeutics	Phase 2
Completed	Instrumented Data Exchange for Ataxia Study NCT04268147	University of Chicago	—
Active Not Recruiting	Troriluzole in Adult Participants With Spinocerebellar Ataxia NCT03701399	Biohaven Pharmaceuticals, Inc.	Phase 3
Active Not Recruiting	Open Pilot Trial of BHV-4157 NCT03408080	University of California, Los Angeles	Phase 3
Completed	Parkinsonism in Spinocerebellar Ataxia Type 6 NCT01934998	University of Chicago	—
Recruiting	Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168	Sanford Health	—
Unknown	Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias NCT01060371	University of Florida	—